HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) CME: Take the course for this article: Volume 67, Number 1, July 11, 2006 Data Supplement Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by McDermott, C. J. Search for Related Content PubMed PubMed Citation Articles by McDermott, C. J.

Clinical features of hereditary spastic paraplegia due to spastin mutation

From the Sheffield Care and Research Centre for Motor Neuron Disorders, Academic Neurology Unit, University of Sheffield, Sheffield, UK (C.J.M., C.E.B., J.K., L.E.C., D.G.R., C.H., B.S., M.H., P.J.S.); Sheffield Molecular Genetics Service, Sheffield Children’s NHS Trust, Sheffield, UK (A.D.); and Department of Neurology, University of Newcastle upon Tyne, Newcastle upon Tyne, UK (P.F.C.).

Address correspondence and reprint requests to Dr Shaw, Academic Neurology Unit, Sheffield University, Sheffield, UK; e-mail: pamela.shaw{at}sheffield.ac.uk

Background: Mutations in the spastin gene are the commonest cause of hereditary spastic paraparesis (HSP), accounting for up to 40% of autosomal dominant cases. The phenotype associated with HSP due to mutation in the spastin gene (SPG4) tends to be pure HSP.

Objective: To characterize in more detail the genetic and phenotypic characteristics of SPG4 by examining a large cohort of patients with HSP.

Methods: The authors identified patients who tested positive for spastin mutation using a direct sequencing approach of all exons.

Results: The authors identified spastin mutations in 53 patients. Twenty-seven of the mutations identified were novel. The phenotype in the majority of patients was of pure HSP. In one individual, a complicated phenotype with progressive bulbar dysfunction and respiratory insufficiency was observed. Evidence of lower motor neuron dysfunction in a subgroup of SPG4 patients was identified. The missense changes S44L and P45Q were identified in patients with other spastin mutations and seemed to be exerting a phenotype-modifying effect.

Conclusion: These findings add to the number of spastin mutations identified and demonstrate the importance of screening the whole gene, given the possibility of double mutations and intragenic modifiers. The identification of the complicated phenotypes has important implications for identifying the phenotype of patients in whom spastin screening should be considered. The presence of lower motor neuron dysfunction in a subgroup of SPG4 patients suggests that the cellular dysfunction in SPG4 extends beyond the axonal projections of upper motor neurons and ascending sensory pathways.

Additional material related to this article can be found on the Neurology Web site. Go to www.neurology.org and scroll down the Table of Contents for the July 11 issue to find the title link for this article.

*See the Appendix for a list of participants in the UK and Irish HSP Consortium.

P.J.S. is supported by the Wellcome Trust and the Motor Neurone Disease Association. P.F.C. is a Wellcome Senior Fellow in Clinical Science. L.E.C. is supported by the Wellcome Trust.

Disclosure: The authors report no conflicts of interest.

Received October 10, 2005. Accepted in final form March 14, 2006.

This article has been cited by other articles:

				L. P. Rowland and T. D. Bird Silver syndrome: The complexity of complicated hereditary spastic paraplegia Neurology, May 20, 2008; 70(21): 1948 - 1949. [Full Text] [PDF]

				C.A.A. Hewamadduma, J. Kirby, C. Kershaw, J. Martindale, A. Dalton, C. J. McDermott, and P. J. Shaw HSP60 IS A RARE CAUSE OF HEREDITARY SPASTIC PARAPARESIS, BUT MAY ACT AS A GENETIC MODIFIER Neurology, May 6, 2008; 70(19): 1717 - 1718. [Full Text] [PDF]

				C. Beetz, R. Schule, T. Deconinck, K.-N. Tran-Viet, H. Zhu, B. P.H. Kremer, S. G.M. Frints, W. A.G. van Zelst-Stams, P. Byrne, S. Otto, et al. REEP1 mutation spectrum and genotype/phenotype correlation in hereditary spastic paraplegia type 31 Brain, April 1, 2008; 131(4): 1078 - 1086. [Abstract] [Full Text] [PDF]

				W. Yu, L. Qiang, J. M. Solowska, A. Karabay, S. Korulu, and P. W. Baas The Microtubule-severing Proteins Spastin and Katanin Participate Differently in the Formation of Axonal Branches Mol. Biol. Cell, April 1, 2008; 19(4): 1485 - 1498. [Abstract] [Full Text] [PDF]

				C. Depienne, E. Fedirko, S. Forlani, C. Cazeneuve, P. Ribai, I. Feki, C. Tallaksen, K. Nguyen, B. Stankoff, M. Ruberg, et al. Exon deletions of SPG4 are a frequent cause of hereditary spastic paraplegia J. Med. Genet., April 1, 2007; 44(4): 281 - 284. [Abstract] [Full Text] [PDF]